Docetaxel IV infusion 20mg “SAWAI” is manufactured by Sawai Pharmaceutical (YJ code: 4240405A1053, standard: 20mg 0.5mL 1 bottle (with solution)). It contains Docetaxel hydrate, an antineoplastic agent that interferes with the growth of cancer cells, indicated for treating various cancers such as breast, lung, and prostate cancer.
Docetaxel IV infusion 20mg “SAWAI”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →